| Oct 16 |
Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know
|
| Oct 16 |
Viking Therapeutics to Report Financial Results for Third Quarter 2024 on October 23, 2024
|
| Oct 14 |
Why Amgen's Obesity Drug — And $5 Billion Opportunity — Led To A Downgrade
|
| Oct 14 |
Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views?
|
| Oct 14 |
Where Will Viking Therapeutics Be in 5 Years?
|
| Oct 13 |
Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit Therapeutics
|
| Oct 13 |
With 74% institutional ownership, Viking Therapeutics, Inc. (NASDAQ:VKTX) is a favorite amongst the big guns
|
| Oct 12 |
The Ultimate Biotech Stock to Buy With $100 Right Now
|
| Oct 10 |
Here's Why Viking Therapeutics, Inc. (VKTX) Fell More Than Broader Market
|
| Oct 10 |
Viking reports data from X-linked adrenoleukodystrophy trial
|
